These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31048866)

  • 1. Empirical models for anatomical and physiological changes in a human mother and fetus during pregnancy and gestation.
    Kapraun DF; Wambaugh JF; Setzer RW; Judson RS
    PLoS One; 2019; 14(5):e0215906. PubMed ID: 31048866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological "constants" for PBPK models for pregnancy.
    Young JF; Branham WS; Sheehan DM; Baker ME; Wosilait WD; Luecke RH
    J Toxicol Environ Health; 1997 Dec; 52(5):385-401. PubMed ID: 9388532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.
    Dallmann A; Ince I; Meyer M; Willmann S; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Nov; 56(11):1303-1330. PubMed ID: 28401479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A physiologically based pharmacokinetic computer model for human pregnancy.
    Luecke RH; Wosilait WD; Pearce BA; Young JF
    Teratology; 1994 Feb; 49(2):90-103. PubMed ID: 8016750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.
    Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S
    Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of a pregnancy PBPK Model for Bisphenol A and its evaluation with the available biomonitoring data.
    Sharma RP; Schuhmacher M; Kumar V
    Sci Total Environ; 2018 May; 624():55-68. PubMed ID: 29247905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in the developing rabbit brain.
    Kim CS; Binienda Z; Sandberg JA
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):250-9. PubMed ID: 8619233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically based pharmacokinetic modeling of fetal and neonatal manganese exposure in humans: describing manganese homeostasis during development.
    Yoon M; Schroeter JD; Nong A; Taylor MD; Dorman DC; Andersen ME; Clewell HJ
    Toxicol Sci; 2011 Aug; 122(2):297-316. PubMed ID: 21622944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal Physiologically Based Pharmacokinetic Models: Systems Information on Fetal Blood Components and Binding Proteins.
    Abduljalil K; Jamei M; Johnson TN
    Clin Pharmacokinet; 2020 May; 59(5):629-642. PubMed ID: 31696406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical modeling of the human fetal arterial blood circulation.
    Guettouche A; Challier JC; Ito Y; Papapanayotou C; Cherruault Y; Azancot-Benisty A
    Int J Biomed Comput; 1992 Aug; 31(2):127-39. PubMed ID: 1517000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling.
    Lin Z; Fisher JW; Wang R; Ross MK; Filipov NM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):140-58. PubMed ID: 23958493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating placental transfer and tissue concentrations of manganese in the pregnant rat and fetuses after inhalation exposures with a PBPK model.
    Yoon M; Nong A; Clewell HJ; Taylor MD; Dorman DC; Andersen ME
    Toxicol Sci; 2009 Nov; 112(1):44-58. PubMed ID: 19726578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.
    De Sousa Mendes M; Lui G; Zheng Y; Pressiat C; Hirt D; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Urien S; Benaboud S
    Clin Pharmacokinet; 2017 May; 56(5):537-550. PubMed ID: 27766562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.
    Abduljalil K; Furness P; Johnson TN; Rostami-Hodjegan A; Soltani H
    Clin Pharmacokinet; 2012 Jun; 51(6):365-96. PubMed ID: 22515555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perchlorate and radioiodide kinetics across life stages in the human: using PBPK models to predict dosimetry and thyroid inhibition and sensitive subpopulations based on developmental stage.
    Clewell RA; Merrill EA; Gearhart JM; Robinson PJ; Sterner TR; Mattie DR; Clewell HJ
    J Toxicol Environ Health A; 2007 Mar; 70(5):408-28. PubMed ID: 17454566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.
    Fisher JW; Whittaker TA; Taylor DH; Clewell HJ; Andersen ME
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):395-414. PubMed ID: 2749729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of physiologically based models of pregnancy and lactation for their application in children's health risk assessments.
    Corley RA; Mast TJ; Carney EW; Rogers JM; Daston GP
    Crit Rev Toxicol; 2003; 33(2):137-211. PubMed ID: 12708613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically based pharmacokinetic prediction of p-phenylbenzoic acid disposition in the pregnant rat.
    Kawahara M; Nanbo T; Tsuji A
    Biopharm Drug Dispos; 1998 Oct; 19(7):445-53. PubMed ID: 9818711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update.
    Alsmadi MM; Idkaidek N
    Curr Drug Metab; 2018; 19(12):972-978. PubMed ID: 29962340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.